---
figid: PMC5267522__mol.116.106617absf1
figlink: /pmc/articles/PMC5267522/figure/absf1/
number: ''
caption: .na.character
pmcid: PMC5267522
papertitle: Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering
  Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
reftext: Runbin Sun, et al. Mol Pharmacol. 2017 Feb;91(2):110-122.
pmc_ranked_result_index: '143591'
pathway_score: 0.9425689
filename: mol.116.106617absf1.jpg
figtitle: Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering
  Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5267522__mol.116.106617absf1.html
  '@type': Dataset
  description: .na.character
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD36
  - SLC51A
  - SLC10A2
  - NR1H4
  - Cholesterol
genes:
- word: CD36
  symbol: CD36
  source: hgnc_symbol
  hgnc_symbol: CD36
  entrez: '948'
- word: OSTas
  symbol: OSTalpha
  source: hgnc_alias_symbol
  hgnc_symbol: SLC51A
  entrez: '200931'
- word: ASBT
  symbol: ASBT
  source: hgnc_prev_symbol
  hgnc_symbol: SLC10A2
  entrez: '6555'
- word: FXR
  symbol: FXR
  source: hgnc_alias_symbol
  hgnc_symbol: NR1H4
  entrez: '9971'
chemicals:
- word: Cholesterol
  source: MESH
  identifier: D002784
diseases: []
---
